{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:40:36Z","timestamp":1762875636918},"reference-count":32,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":427,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hastings Center Report"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1002\/hast.327","type":"journal-article","created":{"date-parts":[[2014,10,7]],"date-time":"2014-10-07T11:22:03Z","timestamp":1412680923000},"page":"17-21","source":"Crossref","is-referenced-by-count":4,"title":["When a Blood Donor Has Sickle Cell Trait:<i>Incidental Findings and Public Health<\/i>"],"prefix":"10.1002","volume":"44","author":[{"given":"Lisa M.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Marks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,7,9]]},"reference":[{"key":"10.1002\/hast.327-BIB0001|hast327-cit-0001","unstructured":"Blood Facts and Statistics American Red Cross, accessed February 18 2014 http:\/\/redcrossblood.org\/learn-about-blood\/blood-facts-and-statistics"},{"key":"10.1002\/hast.327-BIB0002|hast327-cit-0002","volume-title":"Anticipate and Communicate: Ethical Management of Incidental and Secondary Findings in the Clinical, Research, and Direct-to-Consumer Context","author":"Presidential Commission for the Study of Bioethical Issues","year":"2013"},{"key":"10.1002\/hast.327-BIB0003|hast327-cit-0003","unstructured":"Ibid., 28"},{"key":"10.1002\/hast.327-BIB0004|hast327-cit-0004","unstructured":"Keeping Blood Transfusions Safe: FDA's Multi-layered Protections for Donated Blood 2013 http:\/\/www.fda.gov\/BiologicsBloodVaccines\/SafetyAvailability\/BloodSafety\/ucm095522.htm"},{"key":"10.1002\/hast.327-BIB0005|hast327-cit-0005","unstructured":"U.S. Food and Drug Administration Guidance for Industry-Donors of Blood and Blood Components: Notification of Donor Deferral-Small Entity Compliance Guide 2011 http:\/\/www.fda.gov\/biologicsbloodvaccines\/guidancecomplianceregulatoryinformation\/guidances\/blood\/ucm257559.htm"},{"key":"10.1002\/hast.327-BIB0006|hast327-cit-0006","unstructured":"U.S. Food and Drug Administration General Requirements for Blood, Blood Components, and Blood Derivatives"},{"key":"10.1002\/hast.327-BIB0007|hast327-cit-0007","unstructured":"U.S. Food and Drug Administration General Biological Products and Standards"},{"key":"10.1002\/hast.327-BIB0008|hast327-cit-0008","unstructured":"Johns Hopkins Medicine Health Library Sickle Cell Disease 2014 http:\/\/www.hopkinsmedicine.org\/healthlibrary\/conditions\/hematology_and_blood_disorders\/sickle_cell_disease_85,P00101\/"},{"key":"10.1002\/hast.327-BIB0009|hast327-cit-0009","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.tmrv.2004.03.002","article-title":"Leukoreduction Filtration of Blood with Sickle Cell Trait","volume":"18","author":"Schuetz","year":"2004","journal-title":"Transfusion Medicine Reviews"},{"key":"10.1002\/hast.327-BIB0010|hast327-cit-0010","unstructured":"Presidential Commission for the Study of Bioethical Issues Anticipate and Communicate 30 31"},{"key":"10.1002\/hast.327-BIB0011|hast327-cit-0011","unstructured":"Ibid., 43-52"},{"issue":"53","key":"10.1002\/hast.327-BIB0012|hast327-cit-0012","first-page":"1","volume-title":"Morbidity and Mortality Weekly Report","volume":"60","author":"Adams","year":"2013"},{"key":"10.1002\/hast.327-BIB0012.2|hast327-cit-0025","unstructured":"R.E. Hoffmann F. E. Shaw Legal Basis for Infectious Disease Surveillance and Control in the USA Infectious Disease Surveillance 2nd ed."},{"key":"10.1002\/hast.327-BIB0012.3|hast327-cit-0026","unstructured":"N. M. M'ikanatha Hoboken, N.J. John Wiley and Sons 2013 583 93"},{"key":"10.1002\/hast.327-BIB0013|hast327-cit-0013","first-page":"39","volume-title":"Emerging Pervasive Information and Communication Technologies (PICT): Ethical Challenges, Opportunities and Safeguards","author":"Lee","year":"2013"},{"key":"10.1002\/hast.327-BIB0013.2|hast327-cit-0027","first-page":"38","volume-title":"American Journal of Public Health","volume":"102","author":"Lee","year":"2012"},{"key":"10.1002\/hast.327-BIB0013.3|hast327-cit-0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/acprof:oso\/9780195372922.003.0001","volume-title":"Principles and Practice of Public Health Surveillance","author":"Thacker","year":"2010"},{"key":"10.1002\/hast.327-BIB0014|hast327-cit-0014","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/jlme.12048","article-title":"Who's Your Nanny? Choice, Paternalism and Public Health in the Age of Personal Responsibility","volume":"41","author":"Wiley","year":"2013","journal-title":"Journal of Law, Medicine & Ethics"},{"key":"10.1002\/hast.327-BIB0015|hast327-cit-0015","unstructured":"National Collegiate Athletic Association Sickle Cell Trait 2012 http:\/\/www.ncaa.org\/health-and-safety\/medical-conditions\/sickle-cell-trait"},{"key":"10.1002\/hast.327-BIB0016|hast327-cit-0016","unstructured":"What You Should Know about Sickle Cell Trait 2014 http:\/\/www.cdc.gov\/ncbddd\/sicklecell\/documents\/SCD%20factsheet_Sickle%20Cell%20Trait.pdf"},{"key":"10.1002\/hast.327-BIB0017|hast327-cit-0017","unstructured":"Sickle Cell Disease (SCD): Complications and Treatments 2014 http:\/\/www.cdc.gov\/ncbddd\/sicklecell\/treatments.html"},{"issue":"11","key":"10.1002\/hast.327-BIB0018|hast327-cit-0018","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMp1007639","article-title":"Screening Student Athletes for Sickle Cell Trait-A Social and Clinical Experiment","volume":"363","author":"Bonham","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/hast.327-BIB0019|hast327-cit-0019","first-page":"78-0012","volume-title":"The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research","author":"National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research","year":"1978"},{"issue":"2","key":"10.1002\/hast.327-BIB0020|hast327-cit-0020","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2307\/274676","article-title":"Genetic Screening Programs and Public Policy","volume":"38","author":"Bowman","year":"1977","journal-title":"Phylon"},{"key":"10.1002\/hast.327-BIB0020.2|hast327-cit-0029","volume-title":"In the Blood: Sickle Cell Anemia and the Politics of Race","author":"Tapper","year":"1999"},{"issue":"2","key":"10.1002\/hast.327-BIB0021|hast327-cit-0021","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0002-9343(92)90052-D","article-title":"The Stigma of Disease: Implications of Genetic Screening","volume":"93","author":"Markel","year":"1992","journal-title":"American Journal of Medicine"},{"issue":"2","key":"10.1002\/hast.327-BIB0022|hast327-cit-0022","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2307\/274676","article-title":"Genetic Screening Programs and Public Policy","volume":"38","author":"Bowman","year":"1977","journal-title":"Phylon"},{"key":"10.1002\/hast.327-BIB0022.2|hast327-cit-0030","unstructured":"Tapper In the Blood: Sickle Cell Anemia and the Politics of Race"},{"key":"10.1002\/hast.327-BIB0022.3|hast327-cit-0031","volume-title":"Air Academy to Drop Its Ban on Applicants with Sickle-Cell Gene","author":"Severo","year":"1981"},{"key":"10.1002\/hast.327-BIB0022.4|hast327-cit-0032","volume-title":"Perilous Knowledge: The Human Genome Project and Its Implications","author":"Wilkie","year":"1993"},{"key":"10.1002\/hast.327-BIB0023|hast327-cit-0023","unstructured":"Severo Air Academy to Drop Its Ban on Applicants with Sickle-Cell Gene"},{"key":"10.1002\/hast.327-BIB0024|hast327-cit-0024","unstructured":"National Health Service Blood and Transplant Sickle Cell and Blood Donation-Information for Donors 2014 http:\/\/www.blood.co.uk\/video-audio-leaflets\/information-leaflets\/sickle-cell\/"}],"container-title":["Hastings Center Report"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhast.327","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/hast.327","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T07:44:25Z","timestamp":1625298265000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hast.327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"URL":"https:\/\/doi.org\/10.1002\/hast.327","relation":{},"ISSN":["0093-0334"],"issn-type":[{"value":"0093-0334","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}